Insulin injections can control diabetes, but patients still experience serious complications such as kidney disease and skin infections. | Scientists at Washington University in St. Louis developed a way to use CRISPR-Cas9 to edit a mutation in human-induced pluripotent stem cells and then turn them into beta cells. When transplanted into mice, those beta cells reversed preexisting diabetes in a lasting way, a new publication shows.